DE69821987D1 - Omega-cycloalkyl-prostaglandin e2 derivate - Google Patents
Omega-cycloalkyl-prostaglandin e2 derivateInfo
- Publication number
- DE69821987D1 DE69821987D1 DE69821987T DE69821987T DE69821987D1 DE 69821987 D1 DE69821987 D1 DE 69821987D1 DE 69821987 T DE69821987 T DE 69821987T DE 69821987 T DE69821987 T DE 69821987T DE 69821987 D1 DE69821987 D1 DE 69821987D1
- Authority
- DE
- Germany
- Prior art keywords
- omega
- derivatives
- prostaglandin
- cycloalkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003166 prostaglandin E2 derivatives Chemical class 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 208000005107 Premature Birth Diseases 0.000 abstract 1
- 206010036590 Premature baby Diseases 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 230000016273 neuron death Effects 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 210000001525 retina Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP36624497 | 1997-12-25 | ||
| JP36624497 | 1997-12-25 | ||
| PCT/JP1998/005863 WO1999033794A1 (en) | 1997-12-25 | 1998-12-24 | φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69821987D1 true DE69821987D1 (de) | 2004-04-01 |
| DE69821987T2 DE69821987T2 (de) | 2004-12-16 |
Family
ID=18486293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69821987T Expired - Fee Related DE69821987T2 (de) | 1997-12-25 | 1998-12-24 | Omega-cycloalkyl-prostaglandin e2 derivate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6262293B1 (de) |
| EP (1) | EP1042283B1 (de) |
| KR (1) | KR20010033538A (de) |
| AT (1) | ATE260254T1 (de) |
| DE (1) | DE69821987T2 (de) |
| ES (1) | ES2216336T3 (de) |
| WO (1) | WO1999033794A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235780B1 (en) * | 1998-07-21 | 2001-05-22 | Ono Pharmaceutical Co., Ltd. | ω-cycloalkyl-prostaglandin E1 derivatives |
| JP4834224B2 (ja) | 1999-03-05 | 2011-12-14 | デューク ユニバーシティ | Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体 |
| WO2001049661A1 (fr) * | 2000-01-05 | 2001-07-12 | Ono Pharmaceutical Co., Ltd. | ALCOOLS 5-THIA-φ-(PHENYLE SUBSTITUES)- PROSTAGLANDINE E, PROCESSUS DE PREPARATION DE CES ALCOOLS ET PREPARATIONS PHARMACEUTIQUES CONTENANT CES ALCOOLS COMME PRINCIPE ACTIF. |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| JP2002027998A (ja) * | 2000-09-29 | 2002-01-29 | Shionogi & Co Ltd | 神経細胞変性調節活性の測定方法 |
| US6586462B2 (en) | 2000-10-20 | 2003-07-01 | Allergan, Inc. | ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| US6376533B1 (en) * | 2000-10-20 | 2002-04-23 | Allergan Sales, Inc. | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| AU2003224244A1 (en) * | 2002-03-27 | 2003-10-13 | Rosanto Pharmaceuticals Ltd | Improvements in pharmaceutical compositions |
| JP2006021998A (ja) * | 2002-07-18 | 2006-01-26 | Ono Pharmaceut Co Ltd | Ｅｐ２アゴニストを有効成分とする月経困難症治療剤 |
| TW200413000A (en) | 2002-10-10 | 2004-08-01 | Ono Pharmaceutical Co | Intrinsic repair factor producing accelerator |
| WO2004073591A2 (en) * | 2003-02-24 | 2004-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep2 (prostaglandin e2 ep2) |
| CA2513652A1 (en) | 2003-03-03 | 2004-09-16 | Applied Research Systems Ars Holding N.V. | G-lactam derivatives as prostaglandin agonists |
| JP2005511607A (ja) * | 2003-07-10 | 2005-04-28 | アラーガン、インコーポレイテッド | ＥＰ２受容体作動剤としてのω−シクロアルキル１７−ヘテロアリールプロスタグランジンＥ２類似体 |
| CA2529123A1 (en) | 2003-07-18 | 2005-02-10 | Applied Research Systems Ars Holding N.V. | Hydrazide derivatives as prostaglandin receptors modulators |
| EP2422814A1 (de) | 2003-07-25 | 2012-02-29 | Ono Pharmaceutical Co., Ltd. | Heilmittel für Knorpelerkrankungen |
| WO2006043655A1 (ja) | 2004-10-22 | 2006-04-27 | Ono Pharmaceutical Co., Ltd. | 吸入用医薬組成物 |
| AR056968A1 (es) * | 2005-04-11 | 2007-11-07 | Xenon Pharmaceuticals Inc | Compuestos espiro-oxindol y composiciones farmacéuticas |
| AR053710A1 (es) * | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| EP2494990A1 (de) | 2005-06-03 | 2012-09-05 | Ono Pharmaceutical Co., Ltd. | Wirkstoff zur Regenerierung und/oder zum Schutz von Nerven |
| HUE031972T2 (en) | 2005-12-29 | 2017-08-28 | Celtaxsys Inc | Diamin derivatives as leukotriene A4 hydrolase inhibitors |
| TW200833695A (en) | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Use of spiro-oxindole compounds as therapeutic agents |
| CL2007002953A1 (es) * | 2006-10-12 | 2008-02-01 | Xenon Pharmaceuticals Inc | Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia. |
| US8101647B2 (en) * | 2008-10-17 | 2012-01-24 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| RU2011119626A (ru) * | 2008-10-17 | 2012-11-27 | Ксенон Фармасьютикалз Инк. | Спирооксиндольные соединения и их применение в качестве терапевтичеких средств |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| ES2824842T3 (es) | 2009-07-13 | 2021-05-13 | Patheon Api Services Inc | Síntesis de prostanoides |
| WO2011047173A2 (en) | 2009-10-14 | 2011-04-21 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
| EP2488531B1 (de) * | 2009-10-14 | 2014-03-26 | Xenon Pharmaceuticals Inc. | Verfahren zur herstellung von spiro-oxindol derivaten |
| US8299068B2 (en) * | 2010-01-29 | 2012-10-30 | Allergan, Inc. | Therapeutically active cyclopentanes |
| WO2011106729A2 (en) | 2010-02-26 | 2011-09-01 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| WO2013154712A1 (en) | 2012-04-12 | 2013-10-17 | Xenon Pharmaceuticals Inc. | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| US20150272874A1 (en) | 2012-10-29 | 2015-10-01 | Cardio Incorporated | Pulmonary disease-specific therapeutic agent |
| WO2014152229A2 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| US10100028B2 (en) | 2013-09-30 | 2018-10-16 | Patheon Api Services Inc. | Synthesis routes for prostaglandins and prostaglandin intermediates using metathesis |
| JP6449166B2 (ja) | 2013-10-15 | 2019-01-09 | 小野薬品工業株式会社 | 薬剤溶出性ステントグラフト |
| WO2016127068A1 (en) | 2015-02-05 | 2016-08-11 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
| US10385045B2 (en) | 2015-07-23 | 2019-08-20 | Ono Pharmaceutical Co., Ltd. | Compound having EP2 agonist activity |
| WO2017218920A1 (en) | 2016-06-16 | 2017-12-21 | Teva Pharmaceuticals International Gmbh | Asymmetric synthesis of funapide |
| JP7174700B2 (ja) | 2016-12-09 | 2022-11-17 | セルタクシー、エルエルシー | ロイコトリエンａ４ヒドロラーゼの阻害剤としてのモノアミン及びモノアミン誘導体 |
| JP7145154B2 (ja) | 2016-12-09 | 2022-09-30 | セルタクシー、エルエルシー | ロイコトリエンａ４ヒドロラーゼの阻害剤 |
| EP3551608A1 (de) | 2016-12-09 | 2019-10-16 | Celtaxsys Inc. | Anhängende amine und derivate als inhibitoren der leukotrien-a4-hydrolase |
| WO2023127855A1 (ja) * | 2021-12-28 | 2023-07-06 | 大内新興化学工業株式会社 | シクロペンテノン誘導体およびその製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132738A (en) * | 1978-02-23 | 1979-01-02 | Miles Laboratories, Inc. | Preparation of 15-deoxy-16-hydroxyprostaglandins |
| US4275224A (en) | 1978-02-23 | 1981-06-23 | Miles Laboratories, Inc. | 15-Deoxy-16-hydroxy prostaglandins |
-
1998
- 1998-12-24 KR KR1020007007046A patent/KR20010033538A/ko not_active Application Discontinuation
- 1998-12-24 US US09/582,348 patent/US6262293B1/en not_active Expired - Fee Related
- 1998-12-24 ES ES98961522T patent/ES2216336T3/es not_active Expired - Lifetime
- 1998-12-24 DE DE69821987T patent/DE69821987T2/de not_active Expired - Fee Related
- 1998-12-24 WO PCT/JP1998/005863 patent/WO1999033794A1/en not_active Application Discontinuation
- 1998-12-24 AT AT98961522T patent/ATE260254T1/de not_active IP Right Cessation
- 1998-12-24 EP EP98961522A patent/EP1042283B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010033538A (ko) | 2001-04-25 |
| ATE260254T1 (de) | 2004-03-15 |
| DE69821987T2 (de) | 2004-12-16 |
| WO1999033794A1 (en) | 1999-07-08 |
| ES2216336T3 (es) | 2004-10-16 |
| EP1042283A1 (de) | 2000-10-11 |
| EP1042283B1 (de) | 2004-02-25 |
| US6262293B1 (en) | 2001-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69821987D1 (de) | Omega-cycloalkyl-prostaglandin e2 derivate | |
| ATE219054T1 (de) | Omega-zykloalkyl-prostaglandin e2 derivate | |
| DE69901658T2 (de) | Omega-Zykloalkyl-Prostaglandin E1 Derivate | |
| JO2282B1 (en) | Oxazole derivatives | |
| BR9815761A (pt) | Processo a vácuo para a fabricação de copolìmeros de siloxano-oxialquileno | |
| LU91927I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| BR9813767A (pt) | Processo e composição para tratar glaucoma de glc1a | |
| DE60040142D1 (de) | Pyridin-imin polymerisationskatalysator | |
| BG106867A (en) | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory autoimmune and respiratory diseases | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| BR0206955A (pt) | Ligantes de receptores de canabinóides | |
| CA2413190A1 (en) | Methods for treating rheumatic diseases using a soluble ctla4 molecule | |
| BRPI0608216A2 (pt) | agente terapêutico para um tumor, método para tratar um tumor, e, uso de um composto de benzoìla, uma pró-groga do mesmo ou um sal farmaceuticamente aceitável do mesmo | |
| WO2003063791A3 (en) | Non-steroidal analogs of 2-methoxyestradiol | |
| RU94044456A (ru) | Средство для подавления дисфункционального маточного кровотечения | |
| TR200001452T2 (tr) | Bifenilamidin türevleri. | |
| AU2004216182A1 (en) | Selective non-steroidal glucocorticoid receptor modulators | |
| BR9917328B1 (pt) | catalisador para homo e co-polimerização de etileno. | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
| NO20014240L (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| BR0016134A (pt) | Compostos, catalisador para a polimerização de olefinas e processos a preparação de compostos e de um catalisador e para a polimerização de olefinas | |
| SE0002211D0 (sv) | Methods and compositions for prevention of myopia | |
| DK1054869T3 (da) | 3,4-Dihydroquinolin-derivater som inhibitorer for nitrogenmonoxid-synthase (NOS) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |